Art

J-GLOBAL ID：201902223602879456   Reference number：19A2659053

Predictive Factors of Antiparkinsonian Drug Reduction after Subthalamic Stimulation for Parkinson’s Disease

Parkinson病に対する視床下刺激後の抗Parkinson病薬減量の予測因子

Author (7)： SAMURA Kazuhiro (Department of Neurosurgery, International University of Health and Welfare, School of Medicine) ,  MIYAGI Yasushi (Department of Stereotactic and Functional Neurosurgery, Fukuoka Mirai Hospital) ,  KAWAGUCHI Minako (Department of Neurosurgery, Faculty of Medicine, Kyushu University) ,  YOSHIDA Fumiaki (Department of Neurosurgery, Faculty of Medicine, Kyushu University) ,  YOSHIDA Fumiaki (Department of Anatomy and Physiology, Faculty of Medicine, Saga University) ,  OKAMOTO Tsuyoshi (Faculty of Arts and Science, Kyushu University) ,  KAWASHIMA Masatou (Department of Neurosurgery, International University of Health and Welfare, School of Medicine)
Material： Neurologia Medico-Chirurgica  (神経外科)
Volume： 59  Issue： 9  Page： 331-336(J-STAGE)  Publication year： 2019 
JST Material Number： Z0762A  ISSN： 0470-8105  Document type： Article
Article type： 短報  Country of issue： Japan (JPN)  Language： ENGLISH (EN)

Thesaurus term： *Parkinson's disease ,...
Semi thesaurus term： *subthalamic nucleus Deep Brain Stimulation therapy ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=19A2659053&from=J-GLOBAL&jstjournalNo=Z0762A") }}

Author keywords (5)： subthalamic nucleus ,  deep brain stimulation ,  antiparkinsonian drug ,  non-motor symptom ,  Parkinson’s disease

JST classification (2)： Treatment for nervous system diseases in general  (GN05010N) ,  Drug therapy(=pharmacotherapy)for nervous system diseases  (GN05020Y)

Substance index (1)： L-Dopa

Reference (34)：

• 1) Benabid AL, Chabardes S, Mitrofanis J, Pollak P: Deep brain stimulation of the subthalamic nucleus for the treatment of Parkinson’s disease. Lancet Neurol 8: 67-81, 2009
• 2) Benabid AL, Pollak P, Gross C, et al.: Acute and long-term effects of subthalamic nucleus stimulation in Parkinson’s disease. Stereotact Funct Neurosurg 62: 76-84, 1994
• 3) Krack P, Batir A, Van Blercom N, et al.: Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson’s disease. N Engl J Med 349: 1925-1934, 2003
• 4) Limousin P, Pollak P, Benazzouz A, et al.: Effect of parkinsonian signs and symptoms of bilateral subthalamic nucleus stimulation. Lancet 345: 91-95, 1995
• 5) Ferrara J, Diamond A, Hunter C, Davidson A, Almaguer M, Jankovic J: Impact of STN-DBS on life and health satisfaction in patients with Parkinson’s disease. J Neurol Neurosurg Psychiatry 81: 315-319, 2010

Terms in the title (6)： Parkinson病 ,  視床 ,  刺激 ,  抗Parkinson病薬 ,  減量 ,  予測因子